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Regulated processing of nepovirus polyproteins allows the release of mature proteins and intermediate
polyproteins. Infectious cDNA clones of the mild NW isolate of arabis mosaic virus (ArMV) and chimeric
clones incorporating RNA1 segments of Lv, a severe isolate, were generated. Clones containing the Lv X2–
NTB cleavage site were not infectious unless the Lv protease was present. The Lv and NW X2–NTB cleavage
sites differ at positions P6, P4 and P2. In vitro, processing at the X2–NTB site was undetectable or reduced in
chimeric polyproteins containing the Lv X2–NTB site and the NW protease but was restored when both the
Lv protease and X2–NTB site were present. In contrast, cleavage at this site was increased in polyproteins
that contained the NW X2–NTB site and the Lv protease. These results show that the ArMV-Lv protease has
greater activity and is active on a greater range of cleavage sites than that of ArMV-NW.
& 2013 Published by Elsevier Inc.Introduction
Arabis mosaic virus (ArMV) belongs to the genus Nepovirus
(subgroup A), family Secoviridae (Sanfacon et al., 2009). ArMV is
transmitted by the nematode Xiphinema diversicaudatum and has a
wide natural host range (Sanfacon et al., 2011 and references
therein). Nepoviruses have two positive sense, single stranded
genomic RNAs, which are polyadenylated at their 30 end and have
a covalently attached small genome-linked viral protein (VPg) at
their 50 end (for reviews see Mayo and Robinson, 1996; Sanfacon,
2008). The complete nucleotide sequences of RNA1 and RNA2 of the
ArMV isolates NW (from grapevine) and Lv (from Ligustrum vulgare)
have been reported (Dupuis et al., 2008; Wetzel et al., 2004, 2001).
Both isolates can be mechanically inoculated onto Chenopodium
quinoa, resulting in a systemic infection. However, while infection
by ArMV-NW produces a mild mosaic or no symptoms on C. quinoa,
ArMV-Lv infection results in very severe chlorotic and necrotic
symptoms on inoculated and systemic leaves, and necrosis of thelsevier Inc.
infectious clones have been
been assigned the accession
rMV NW RNA 2).
(T.-n. Wetzel).
ologie, Institute of Emerging
es, France.apical part of the plant, leading eventually to the death of the plant
(Dupuis et al., 2008).
ArMV RNA1 is translated into a polyprotein (P1), which is
proteolytically matured by the RNA1-encoded protease. The poly-
protein contains ﬁve cleavage sites that delineate six protein
domains referred to as X1 (of unknown function), X2 (often referred
to as a putative protease cofactor by analogy to the related 32 kDa
comovirus protein), NTB (putative helicase), VPg, protease (Pro) and
polymerase (Pol) (Wetzel et al., 2008). Studies on another nepovirus
(tomato ringspot virus, ToRSV) revealed that X2 and NTB are
integral membrane proteins targeted to endoplasmic reticulum
membranes, the site of RNA replication (Han and Sanfacon, 2003;
Wang et al., 2004; Zhang and Sanfacon, 2006; Zhang et al., 2005).
Using a partial polyprotein (X1–Pro, containing the X1, X2, NTB, VPg
and Pro domains) derived from the NW isolate, we have previously
shown that cleavage at the X2–NTB and VPg–Pro sites is sub-
optimal at least in vitro, allowing the accumulation of the X2–NTB
and VPg–Pro intermediate polyproteins (Wetzel et al., 2008).
The RNA2 polyprotein (P2) is cleaved in trans by the RNA1-
encoded protease to release three ﬁnal products referred to as 2A,
the movement protein (MP) and the coat protein (CP) (Margis et al.,
1993; Wetzel et al., 2001). In the related grapevine fanleaf virus
(GFLV), the 2A protein, also called the homing protein, has been
implicated in the replication of RNA2 (Gaire et al., 1999).
Viral proteins may have distinct activities depending on
whether they accumulate as mature proteins or as part of a stable
intermediate polyprotein. For example, previous studies on GFLV
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VPg–Pro intermediate polyprotein have proteolytic activities, the
mature Pro is more active on P2 cleavage sites than the VPg–Pro
intermediate precursor (Chisholm et al., 2001; Margis et al., 1994).
Thus, regulation of proteolytic processing can have profound
effects on the activities of the viral proteins. Nepovirus proteases
are related to the 3C protease of picornaviruses. However, the
proteases of subgroup A and B nepoviruses are unique in their
cleavage site speciﬁcity and have a leucine in their substrate-
binding pocket at the position corresponding to the conserved
histidine found in most viruses of the order Picornavirales
(Gorbalenya et al., 1989; Gorbalenya and Snijder, 1996; Margis
and Pinck, 1992; Ryan and Flint, 1997). The cleavage sites recog-
nized by the ArMV protease are diverse, including dipeptides R/G,
G/V, C/G, C/S and C/A and differ from the Q/G or Q/S cleavage sites
recognized by most picorna-like viruses (Wetzel et al., 2008).
Factors inﬂuencing the speciﬁcity of subgroup A and B nepovirus
proteases are not well understood.
In this manuscript, we report the construction of full-length
infectious clones of the grapevine isolate ArMV-NW, and their use
to construct chimeric clones introducing fragments of the Lv
isolate into the RNA1 of ArMV-NW. We provide evidence that
the protease of ArMV-Lv has greater activity and is active on a
greater range of cleavage sites than that of ArMV-NW, inﬂuencing
the infectivity of chimeric clones.Results
Construction of the ArMV-NW full-length infectious clones
The ArMV-NW clones corresponding to RNA1 or RNA2 were
assembled in plasmid pCassII as described in Materials and
methods. The resulting full-length clones (accession numbers
KC138732 and KC138733 corresponding respectively to RNA1
and RNA2) were 98% and 99% identical to the previously published
sequences (Wetzel et al., 2004, 2001). These changes correspond
to silent mutations introduced to generate new restriction sites,
and to variability in the sequence either naturally present in the
viral population or introduced through the RT/PCR-ampliﬁcation
of cDNA fragments synthesized from puriﬁed viral RNA. Mechan-
ical inoculation of the plasmids corresponding to RNA1 and RNA2
onto C. quinoa resulted in a systemic infection. Both inoculated and
systemic leaves tested positive by ELISA (14 dpi) indicating that
the ArMV-NW clones were infectious. No symptoms, or occasion-
ally a very mild mosaic, were observed on systemic leaves, as for
the native virus.
Analysis of chimeric clones incorporating segments of ArMV-Lv RNA1
ArMV NW/Lv chimeric clones were constructed by swapping
ArMV-NW fragments with the corresponding PCR-ampliﬁed cDNA
fragments from the Lv isolate. We focussed on RNA1, which
encodes the protease and ﬁve cleavage sites. Comparing the
deduced amino acid sequence of the RNA1 polyprotein from the
two ArMV isolates revealed a percentage of sequence identity of
78% for the X1 and VPg domains, 86% for X2, 90% for Pro and 94%
for NTB. Chimeric RNA1 clones were inoculated together with the
ArMV-NW RNA2 clone onto C. quinoa. The plants were subse-
quently tested by ELISA (12 dpi) and by Northern blots, and in
parallel monitored for symptom development during the course of
infection.
As shown in Fig. 1, clones introducing segments of the coding
regions for ArMV-Lv X1 (SexAI/Bsu36I fragment) and NTB (XhoI/
XhoI fragment) were infectious. There were no noticeable differ-
ences in symptom development compared to plants infected withthe wild-type ArMV-NW clones. Northern blot analysis using
probes speciﬁc for the ArMV-NW RNA2-encoded MP–CP coding
region or the ArMV-NW RNA1-encoded Pol coding region revealed
that the accumulation of viral RNA1 or RNA2 was similar in plants
infected with ArMV-NW, or with the infectious chimeric con-
structs containing the ArMV-Lv X1 and NTB coding regions
(Fig. 1B). Accumulation of RNA1 and RNA2 was respectively,
1.270.3 and 1.670.3 times that of ArMV-NW for the X1 clone;
and 1.470.2 and 1.470.1 times that of ArMV-NW for the NTB
clone (numbers shown with standard deviation based on three
independent experiments). Thus, the X1 and NTB proteins of
ArMV-Lv were functional when expressed from the ArMV-NW
genome.
Clones introducing the entire coding regions for VPg (MluI/
PmaCI fragment, also including ﬁve amino acids upstream of the
NTB–VPg cleavage site), Pro (PmaCI/SacII fragment, also including
the four amino acids upstream of the VPg–Pro site) and VPg–Pro
(MluI/SacII fragment) were also infectious (Fig. 1). The accumula-
tion of viral RNAs (especially RNA2) was generally increased in
plants inoculated with chimeric constructs that contained the
ArMV-Lv protease coding region when compared to ArMV-NW
(2.971.7 and 7.574.1 times for RNA1 and RNA2, respectively,
based on three independent experiments). Symptoms induced
following inoculation of the ArMV-NW chimeric constructs con-
taining the Pro coding region of ArMV-Lv were not different from
those induced by the ArMV-NW wild-type construct (data not
shown).
A clone containing most of the ArMV-Lv X2 coding region
(BamHI/MluI fragment, which ended at the X2–NTB G/V cleavage
site), was not infectious. However, clone X2 (12) in which the
last 12 amino acids of the X2 domain were restored to the ArMV-
NW sequence, was infectious. Accumulation of viral RNA1 or RNA2
was similar in plants infected with the X2 (12) construct
compared to plants infected with the WT construct (1.070.4
and 0.970.4 times for RNA1 and RNA2 respectively, based on
three independent experiments, Fig. 1B). This result suggests that
the last 12 amino acids of the ArMV-Lv X2 domain were not
tolerated in the context of the ArMV-NW genome. This region of
the polyprotein is highly divergent between the two isolates with
six changes over the 12 amino acids (see Fig. 1C, X2–NTB (12)).
Incorporating the coding region for the ArMV-Lv protease into the
non-infectious X2 clone restored its infectivity (clone X2+Pro,
Fig. 1). Because the sequence upstream of cleavage sites is
normally involved in regulating their recognition by the protease,
these results raised the possibility that the ArMV-Lv X2–NTB
cleavage site is recognized inefﬁciently by the ArMV-NW protease.
Analysis of chimeric clones incorporating cleavage sites of ArMV-Lv
To further investigate the role of proteolytic cleavage on the
infectivity of ArMV RNA1 clones, we ﬁrst inactivated individual
cleavage sites in the ArMV-NW RNA1 cDNA clone by precisely
deleting the codons for the dipeptide at the scissile bond (Fig. 1A).
The deleted dipeptides were C/G at the junction between X1 and
X2 (clone ΔXX CS), G/V at the X2–NTB junction (clone ΔXN CS), C/S
at the NTB–VPg junction (clone ΔNV CS) and R/G at the VPg–Pro
junction (clone ΔVP CS). These mutations were previously shown
to prevent cleavage site recognition by the ArMV-NW protease
in vitro (Wetzel et al., 2008). As will be discussed below, these
mutations also prevent cleavage site recognition in the ArMV-Lv
polyprotein in vitro (Fig. 2C). Deletion of any of these dipeptides
abolished the infectivity of the cDNA clones (Fig. 1A).
Comparison of the sequence around the cleavage sites (posi-
tions P6–P10) revealed that the X2–NTB site is the most divergent
between the two ArMV isolates with three non-conserved changes
at positions P2, P4 and P6 (Fig. 1C). The NTB–VPg and VPg–Pro
Fig. 1. Infectivity of chimeric RNA1 cDNA clones. (A) Schematic representation of the chimeric clones. The infectious clone corresponding to ArMV-NW RNA1 is shown on
top, with the restriction sites used during the cloning procedures to generate the different chimeric constructs (from left to right: Sx: SexAI, Bs: Bsu36I, B: BamHI, M: MluI, X:
XhoI, P: PmaCI, S: SacII). The coding region and the 30 and 50 non-coding regions are indicated by the thick and thin black lines, respectively. The fragments exchanged in the
different chimeric constructs are represented as red boxes. Infectious constructs are indicated as + and non-infectious constructs as  . (B) Evaluation of viral RNAs
accumulation in plants infected with key chimeric constructs. Total RNA was extracted at 12 dpi from plants inoculated with the different constructs and then analyzed by
Northern hybridization. The loading controls (LC, ethidium bromide stain of a ribosomal RNA band) are shown at the bottom. The probe NW1 corresponds to a 0.3 kb
fragment within the polymerase gene of ArMV-NW RNA1, and the probe NW2, to a 0.4 kb fragment within the movement protein-coat protein genes of ArMV-NW RNA2.
The probes were homologous to ArMV-NW and to all the chimeric constructs tested. (C) Comparison of the sequence of each cleavage site for the NW and Lv ArMV isolates.
For each cleavage site, amino acids at positions P6–P10 are shown. The scissile bond is indicated by the forward slash. Amino acids that differ between the two isolates are
shown in red. The sequence shown corresponds to the sequence exchanged in clones XN CS, NV CS and VP CS. For the X2–NTB site, an extended sequence is shown at the
bottom of the table [X2–NTB (12)]. This longer sequence corresponds to the amino acids exchanged in the X2 (12) and XN CS2 clones.
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Fig. 2. Comparison of the proteolytic processing of polyproteins derived from the RNA1 of ArMV-NW or ArMV-Lv isolates. (A) Schematic representation of the sequential proteolytic
cleavage of the X1–Pro polyprotein. The precursor is shown at the top of the ﬁgure with the small vertical lines representing the cleavage sites. The large arrow indicates the rapid co-
translational cleavage occurring at the X1–X2 cleavage site. Cis-cleavage of the X2–Pro intermediate (shown below the second arrow) allows the release of various cleavage products
depending on the site of cleavage. Since cleavage at the X2–NTB, NTB–VPg and VPg–Pro sites does not occur in trans (Wetzel et al., 2008), the NTB–VPg or NTB protein can only be
released from the NTB–Pro precursor by a second cleavage at the NTB–VPg or VPg–Pro site (shown by the third arrow). (B) Pulse-chase experiment showing the rapid co-translational
release of X2–Pro and X1 cleavage products and the post-translational release of other cleavage products. Translations were conducted in the presence of labeled methionine at 30 1C
for 80 min (pulse) and were followed by incubation at 16 1C in processing buffer containing cold methionine (chase) for the period of time indicated above each lane. Translation
products were separated by SDS–PAGE (gradient gel 8–16% polyacrylamide). X1–Pro polyproteins derived from the wild-type (WT) NW or Lv isolates of ArMV were analyzed along
with a mutated derivative of each polyprotein in which the protease was inactivated by a histidine to serine (HS) or histidine to alanine (HA) mutation in the catalytic triad. Processing
products present in the translation products of the WT polyproteins but not in the polyproteins with inactive proteases are shownwith black diamonds and labeled on the right of the
gel. The lower panel shows a longer exposure of the bottom of the gel to help visualize the X2 cleaved product. Migration of molecular mass markers is shown on the left of the gel.
(C) Conﬁrmation of the nature of the ArMV-Lv cleavage products by mutation of each individual cleavage site. Dipeptides corresponding to previously characterized cleavage sites
(Wetzel et al., 2008) were deleted in the ArMV-Lv X1–Pro polyprotein to give rise to the ΔXX CS mutant (deletion of the C/G at the X1–X2 cleavage site), ΔXN CS mutant (deletion of
G/V at the X2–NTB cleavage site), ΔNVmutant (deletion of C/S at the NTB–VPg cleavage site) and ΔVPmutant (deletion of R/G at the VPg–Pro cleavage site). Translations were done as
described in (B) and incubated in processing buffer for 16 h prior to loading the gel. The translation products were run on an 8% gel to separate the larger processing products (upper
panel) and on an 8–16% gradient gel to separate the smaller processing products (lower panels). The relevant portion of each gel is shown along with the migration of molecular mass
markers (on the left of each gel).
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respectively. The X1–X2 and Pro–Pol cleavage sites are identical
between the two isolates. Using site-directed mutagenesis, we
introduced mutations in the ArMV-NW isolate to reconstitute the
sequence around the ArMV-Lv NTB–VPg, VPg–Pro and X2–NTB
cleavage sites (positions P6–P10). Chimeric clones with the ArMV-
Lv NTB–VPg and VPg–Pro cleavage sites (clones NV CS, VP CS and
NV+VP CS) retained their infectivity (Fig. 1). However, clones
containing the ArMV-Lv X2–NTB cleavage site alone or in combi-
nation with other mutated cleavage sites were not infectious. An
additional clone in which the exchanged sequence was extended
to include the 12 amino acids upstream of the ArMV-Lv X2–NTB
cleavage site (clone XN CS2) was also not infectious. Sub-cloning
the ArMV-Lv protease coding region into the clone containing the
ArMV-Lv X2–NTB cleavage site rendered this clone infectious
(clone XN CS+Pro). In plants infected with this construct, accu-
mulation of RNA1 and RNA2 was generally increased compared to
plants infected with the WT construct (2.170.6 and 7.572.3
times for RNA1 and RNA2 respectively, based on three indepen-
dent experiments). This was similar to results obtained with
clones that only incorporated the ArMV-Lv protease coding region.
Taken together, the results conﬁrm the notion that introduction of
the region upstream of the ArMV-Lv X2–NTB cleavage site is not
viable in the context of ArMV-NW RNA1 unless the ArMV-Lv
protease is also present.In vitro processing of RNA1-derived polyproteins by the ArMV-Lv and
ArMV-MW proteases
To test whether proteolytic cleavage of the RNA1-encoded
polyprotein differed between the two ArMV isolates and in the
various chimeric clones, we conducted in vitro processing assays
using polyproteins containing the X1, X2, NTB, VPg and Pro
domains of ArMV-NW or ArMV-Lv (X1–Pro construct, Fig. 2A).
As the sequence immediately around the Pro-Pol cleavage site is
identical between ArMV-NW and ArMV-Lv (Fig. 1C), this cleavage
site and the Pol region were not included in the polyproteins. We
have previously shown that the X1–Pro polyprotein of ArMV-NW
is cleaved at all four sites but that processing of the X2–NTB and
VPg–Pro cleavage sites is suboptimal, allowing accumulation of the
X2–NTB and VPg–Pro intermediate polyproteins (Wetzel et al.,
2008). We also showed that cleavage at the X1–X2 site can occur
in trans, while all other cleavage sites are only cleaved in cis
(Wetzel et al., 2008).
In vitro processing of the ArMV-Lv and ArMV-NW X1–Pro poly-
protein was similar but showed some differences. Because the X1,
VPg–Pro and Pro proteins of ArMV-Lv migrated at slightly different
positions than the corresponding proteins of ArMV-NW (Fig. 2B), we
ﬁrst conﬁrmed the nature of the ArMV-Lv processing products by
mutating each cleavage site individually (Fig. 2C). Deletion of the C/G
dipeptide between X1 and X2 (ΔXX CS) prevented the release of the
Fig. 3. Proteolytic processing of X1–Pro polyproteins derived from the RNA1 of
various chimeric constructs. (A) Proteolytic processing of chimeric X1–Pro poly-
proteins containing protein domains derived from ArMV-Lv. The pCITE constructs
were derived by sub-cloning the X1–Pro domain from the corresponding pCassII
constructs (shown in Fig. 1) into pCITE 4a. In vitro processing assays were
conducted as indicated in Fig. 2C. The translation products were separated by
SDS–PAGE. The top panel shows the relevant portion of an 8% polyacrylamide gel
that allowed separation of the larger translation products. The lower panels show
the relevant portions of an 8–16% acrylamide gradient gel that allowed separation
of the smaller translation products. (B) Proteolytic processing of X1–Pro polypro-
teins containing cleavage sites from ArMV-Lv introduced individually or in
combinations. Construction of pCITE plasmids, in vitro processing assays and gel
separation of the translation products were as described in (A).
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the G/V dipeptide at the X2–NTB site (ΔXN CS) prevented the release
of the NTB–Pro and X2 cleavage products. The X2–NTB and VPg–Pro
products were not detected after deletion of the C/S dipeptide
between NTB and VPg (ΔNV CS). Finally, deletion of the R/G dipeptide
at the VPg–Pro site (ΔVP CS) hindered the release of the X2–VPg and
Pro cleavage products. Mutation of the histidine of the catalytic triad of
the protease to a serine (Lv-HS) prevented the processing of the
polyprotein. Detection of the predicted NTB or NTB–VPg in ArMV-Lv
X1–Pro cleavage products was obscured by a background band that
was also present in the translation products of the Lv-HS mutant.
A time-course experiment indicated that cleavage between X1
and X2 was rapid for both ArMV-NW and ArMV-Lv X1–Pro
polyproteins allowing the initial release of the X1 and X2–Pro
cleavage products (Fig. 2B). Cleavage at the X2–NTB, NTB–VPg and
VPg–Pro cleavage sites was slower and other cleavage products
accumulated at later time points. The relative ratios of these
secondary cleaved products varied with the isolate. In ArMV-
NW, the X2–NTB and VPg–Pro intermediate polyproteins were
predominant although NTB, Pro and X2 were also detected. This
conﬁrmed our previous observation that cleavage of the ArMV-
NW X1–Pro polyprotein at the X2–NTB and VPg–Pro sites is
inefﬁcient (Wetzel et al., 2008). In ArMV-Lv, three large inter-
mediate products accumulated (NTB–Pro, X2–NTB and X2–VPg)
indicating cleavage occurred at the X2–NTB, NTB–VPg and VPg–
Pro cleavage sites. The VPg–Pro and Pro cleaved products were
both detected and the ratio of Pro to VPg–Pro was higher for
ArMV-Lv than for ArMV-NW. X2 was also detected in the ArMV-Lv
cleavage products although in low amounts.
Next, we analyzed the in vitro processing of chimeric X1–Pro
constructs incorporating various domains of ArMV-Lv (Fig. 3). In
all cases, processing at the X1–X2 cleavage site remained pre-
dominant, as shown by the accumulation of the X1 and X2–Pro
cleavage products. Processing at the VPg–Pro cleavage site was
inﬂuenced by the nature of the Pro domain present in the
polyprotein (Fig. 3A). Polyproteins containing the ArMV-NW Pro
domain showed a high ratio of VPg–Pro to Pro and detection of
X2–NTB but not X2–VPg. This was similar to the pattern observed
for WT ArMV-NW. Polyproteins incorporating the ArMV-Lv Pro
domain showed a pattern similar to that of WT ArMV-Lv with
detection of Pro, VPg–Pro, X2–NTB and X2–VPg in the processing
products. The results indicate that the presence of the ArMV-Lv
protease in the ArMV-NW X1–Pro polyprotein led to increased
cleavage at the VPg–Pro site and release of larger amounts of
mature Pro relative to the VPg–Pro intermediate.
Processing at the X2–NTB cleavage site (as evaluated by the
accumulation of the X2 processing product) was undetectable in
the polyprotein containing the ArMV-Lv X2 domain but restored in
the X2 (12) polyprotein or in the X2 + Pro polyprotein (Fig. 3A).
Similarly, cleavage at the X2–NTB site was decreased in all mutants
that incorporated the ArMV-Lv X2–NTB cleavage site either alone
or in combination with other cleavage sites (Fig. 3B) but was
restored in the XN CS + Pro polyprotein. Thus, mutations that
resulted in non-infectious clones (incorporation of X2 domain or
XN CS) showed decreased cleavage at the X2–NTB site, suggesting
that this reduced cleavage may have contributed to the lack of
infectivity of these clones. On the other hand, cleavage at the
ArMV-NW X2–NTB site was increased in constructs containing the
Pro or VPg–Pro domains of ArMV-Lv as evidenced by the increased
accumulation of the X2 processing product (Fig. 3A).
Analysis of trans-processing of RNA2 polyprotein processing by RNA1
chimeric constructs.
We also investigated the trans processing of the RNA2-encoded
polyprotein (P2) by the ArMV-Lv and ArMV-NW proteases(Fig. 4A). Although two cleavage sites are present in P2, processing
of the related GFLV P2 was previously shown to occur predomi-
nantly at the MP–CP site, resulting in the accumulation of the
intermediate 2A–MP polyprotein in addition to the CP, 2A and MP
mature proteins (Margis et al., 1993). As a source of protease, we
used unlabeled translation products of the X1–Pro polyprotein.
The protease contained within this polyprotein was previously
shown to be active in trans on the X1–X2 cleavage site either as a
mature protease or as an intermediate polyprotein (VPg–Pro or
larger precursors) (Wetzel et al., 2008). Equivalent amounts of the
X1–Pro translation products were added to each reaction as
described in Materials and methods. Because all RNA1 chimeric
constructs tested for infectivity were co-inoculated with the RNA2
full-length construct derived from ArMV-NW, we studied the
processing of the ArMV-NW P2. As expected, processing occurred
predominantly at the MP–CP cleavage site, resulting in the release
of the 2A–MP, CP, 2A and MP cleavage products (Fig. 4B). Proces-
sing was efﬁcient after addition of the ArMV-Lv X1–Pro translation
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contrast, processing was slower after addition of the ArMV-NW
X1–Pro translation products, and the 2A–MP cleavage product was
the main product detected. Analysis of representative chimeric
X1–Pro clones revealed that processing of the ArMV-NW P2 at the
2A–MP cleavage site was increased for constructs that incorpo-
rated the Pro or VPg–Pro domain of ArMV-Lv (Fig. 4C).Discussion
We describe the construction of infectious cDNA clones of
ArMV and their use to evaluate the effect of exchanging portionsFig. 4. Efﬁciency of trans-processing of ArMV-NW RNA2 polyprotein directed by
the X1–Pro translation products of key chimeric constructs. (A) Schematic repre-
sentation of the proteolytic cleavage of the P2 polyprotein containing the 2A, MP
and CP domains. Cleavage sites are represented by the short vertical lines. The large
arrow represents the efﬁcient cleavage at the MP–CP site allowing the release of CP
and the 2A–MP intermediate polyprotein. The smaller arrow represents the
inefﬁcient cleavage at the 2A–MP site allowing the release of 2A and MP.
(B) Trans-processing of P2 by the X1–Pro translation products of ArMV-Lv and
ArMV-NW. Trans-processing assays were conducted as described in Materials and
methods. The radiolabeled translation products of P2 (derived from the ArMV-NW
RNA2 sequence) were incubated with the cold translation products of various
X1–Pro constructs as indicated above each lane. The processing reactions were
allowed to proceed for the period of time indicated above each lane. The nature of
the processing products is indicated by arrows on the right and by black diamonds.
Migration of the molecular mass markers is shown on the left. (C) Trans-processing
of P2 by the X1–Pro translation products of representative chimeric constructs.
Assays were conducted as described in B using cold translation products from the
wild-type ArMV-NW X1–Pro, or from chimeric X1–Pro polyproteins containing the
VPg, Pro or VPg–Pro domains of ArMV-Lv as indicated above each lanes.of RNA1-encoded polyprotein coding regions between two isolates
with varying degrees of virulence. Introduction of the X1, NTB, VPg
or Pro coding region of the severe isolate (Lv) into RNA1 from the
mild isolate (NW) resulted in a systemic infection in C. quinoa,
conﬁrming that the ArMV-Lv proteins are functional in the context
of the ArMV-NW genome. A construct containing most of the X2
coding region of ArMV-Lv (excluding the C-terminal 12 amino
acids) and a construct containing the complete X2 and Pro coding
regions of ArMV-Lv were also infectious. Plants inoculated with
these exchange mutants did not show signiﬁcant symptoms, as
was also seen with plants inoculated with the wild-type NW
isolate. This differed from the severe symptoms induced by the Lv
isolate. Although we cannot exclude the possibility that these
proteins could alter symptom formation in combination with
other proteins, our results suggest that the RNA1-encoded X1,
X2, NTB, VPg and Pro proteins of ArMV (or the corresponding
nucleotide sequence of their coding regions) are not primary
symptom determinants. These results also suggest that symptom
severity determinants could be located in the RNA1-encoded
polymerase, in the RNA2-encoded proteins, and/or in the non-
coding regions of arabis mosaic virus. In contrast, in a previous
study with a comovirus (bean pod mottle virus), the protease co-
factor (which shares conserved sequence motifs with X2) and the
putative helicase (corresponding to the NTB protein) were identi-
ﬁed as symptom severity determinants (Gu and Ghabrial, 2005).
The C-terminal region of X2 (i.e. the six amino acids upstream of
the X2–NTB cleavage site) is crucial for determining the infectivity of
the full-length RNA1 cDNA clones. Chimeric clones that included the
coding region for the Lv X2 C-terminal region were not infectious
unless they also included the Lv protease coding region. One possible
explanation is that the protease interacts in a speciﬁc manner with
the C-terminal region of X2. Nepovirus X2 proteins share conserved
sequence motifs with the comovirus 32 kDa protein, a co-factor of
the protease (Peters et al., 1992). So far, there is no evidence that X2
plays a similar role and its presence on P1-derived polyprotein
precursors does not seem to affect the activity of the protease
(Wang and Sanfacon, 2000; Wetzel et al., 2008). However, these
results do not exclude the possibility that an interaction between the
C-terminal region of X2 and the protease plays other important roles
(e.g., in viral RNA replication). Another interpretation of our results is
that processing at the sub-optimal X2-NTB site is essential for virus
infectivity. Indeed, all constructs that were deﬁcient in cleavage at
the X2–NTB site in vitro were non-infectious. X2 and NTB have
hydrophobic domains that allow their association with endoplasmic
reticulum membranes (Han and Sanfacon, 2003; Wang et al., 2004;
Zhang and Sanfacon, 2006; Zhang et al., 2005). They probably act as
membrane anchors for the replication complex and may modify
membranes to form vesicles that house the replication complex.
Regulated processing at the X2–NTB cleavage site may affect the
topology of these proteins in the membrane (reviewed in Sanfacon,
2013). Thus, it is possible that the regulated release of the mature
ArMV X2 and NTB proteins allows timely modiﬁcation of membranes
for optimal viral replication. Similarly, processing at the sub-optimal
cleavage site between the poliovirus 2B and 2C proteins, the
functional equivalents of the nepovirus X2 and NTB proteins, was
shown to be essential for infectivity (van Kuppeveld et al., 1996).
Inoculation with chimeric constructs that include the Lv Pro
resulted in a general increase in the accumulation of RNA2, and to
a lesser extent of RNA1. Nepovirus proteases are multifunctional
proteins that not only direct proteolytic processing of the two viral
polyproteins but also interact with host factors such as eIF4E
(Leonard et al., 2002). Nepovirus proteases may also interact with
the viral RNA and play a direct role in viral replication, as has been
shown for picornavirus proteases (Blair et al., 1996; Ryan and Flint,
1997). One or several of these known or putative activities are
probably performed more efﬁciently by the ArMV-Lv protease
T. Wetzel et al. / Virology 446 (2013) 102–111108than the –NW protease, thereby contributing to increased viru-
lence. The increased cleavage at the RNA2-encoded 2A–MP and
MP–CP cleavage site observed with chimeric constructs containing
the Lv Pro may also contribute to elevated viral RNA accumulation
by enhancing viral encapsidation and cell-to-cell movement. The
GFLV 2A protein is implicated in the replication of RNA2 but not of
RNA1 (Gaire et al., 1999). Thus, the speciﬁc increase in accumula-
tion of RNA2 in plants infected with clones containing the ArMV-
Lv protease could also be due at least in part to the increased
release of the mature 2A protein.
In vitro cleavage at the X2–NTB site, the most divergent
cleavage site among ArMV isolates, was inﬂuenced by the nature
of the cleavage site and of the protease. In wild-type polyproteins,
both proteases recognized the cognate X2–NTB cleavage site with
moderate efﬁciency, leading to the accumulation of the X2–NTB
and/or X2–VPg intermediates. In chimeric polyproteins, introduc-
tion of the ArMV-Lv sequence upstream of the X2–NTB junction
hindered the recognition of this cleavage site by the ArMV-NW
protease. On the other hand, introduction of the ArMV-Lv protease
in the ArMV-NW polyprotein resulted in increased cleavage at the
X2–NTB site. The speciﬁcity of 3C-like proteases is determined by
their substrate binding pocket that interacts with amino acids at
positions P6–P10 of the cleavage site. The amino acid at the P1
position (usually a glutamine) is the most important (Bergmann
et al., 1997; Blair et al., 1996; Gorbalenya et al., 1989; Kuehnel et al.,
2004; Mosimann et al., 1997; Zunszain et al., 2010). Other factors
such as the conformation of the protein around the cleavage site
and the nature of the cleavage (cis or trans cleavage) also inﬂuence
cleavage site speciﬁcity (Carrier et al., 1999; Clark et al., 1999;
Ypma-Wong et al., 1988). The proteases of nepoviruses of sub-
groups A (including ArMV) and B recognize a variety of cleavage
sites that have cysteine, glycine, arginine or lysine at the P1
position (Gorbalenya et al., 1989; Margis and Pinck, 1992;
Sanfacon et al., 2011). The regulation of the cleavage site speciﬁcity
of subgroup A or B nepoviruses has so far not been studied.
Analysis of the amino acid sequence around the ArMV X2–NTB site
(positions P6–P10) reveals three differences between the two
isolates: substitution of a methionine (ArMV-NW) for an arginine
(ArMV-Lv) at the P2 position, of a valine for a threonine at the P4
position and of a serine for an aspartic acid at the P6 position
(Fig. 5A). The X2–NTB cleavage sites of other recently sequenced
ArMV isolates are either identical to that of ArMV-Lv (barley
isolates Ba1–Ba3, with the exception of a conserved arginine to
lysine substitution at the P2 position) or to that of ArMV-NW
(grapevine isolate DU13, with the exception of a conserved valine
to isoleucine substitution at the P4 position) (Fig. 5A). Examination
of the cleavage site speciﬁcity of the ToRSV protease revealed a
preference for a cysteine, valine or alanine at the P2 position, and
substitution to an arginine drastically reduces the recognition of
the cleavage site (Carrier et al., 1999). By analogy, it is possible that
the methionine to arginine substitution at the P2 position of the
ArMV-Lv X2–NTB cleavage site contributes to its decreased recog-
nition by both proteases, although further study will be necessary
to clarify the contribution of this and other amino acid substitu-
tions to the regulation of cleavage efﬁciency at the X2–NTB site.
Resolution of the 3D structure of picornavirus 3C proteases and
site-directed mutagenesis studies have identiﬁed amino acids of
the protease substrate-binding pocket and their contact points
with the cleavage sites (Allaire et al., 1994; Blair et al., 1996;
Matthews et al., 1994; Mosimann et al., 1997; Sweeney et al.,
2007). A conserved histidine and threonine (His161 and Thr142, in
the case of poliovirus) as well as surrounding amino acids (Gly163,
Gly164, Gly145, Gln146) interact with the conserved glutamine at the
P1 position of the cleavage site. In the case of nepoviruses of
subgroup A and B, the absence of a glutamine at the P1 position of
cleavage sites is correlated with the replacement of the histidinein the substrate-binding pocket of the protease by a leucine
(Gorbalenya et al., 1989; Gorbalenya and Snijder, 1996; Margis
and Pinck, 1992; Ryan and Flint, 1997). An equivalent to Thr142 is
not found in the sequence of subgroup A and B nepovirus
proteases. Mutation of Leu197 in the substrate-binding pocket
and of His43, Glu87 and Cys179 of the catalytic triad abolished the
activity of the GFLV protease, with the exception of a tolerated
Cys179 to Ser mutation (Margis and Pinck, 1992). However, the
contribution of other amino acids to the activity and speciﬁcity of
subgroup A nepovirus proteases is not known. The ArMV Lv and
NW proteases share 90% sequence identity, corresponding to 22
amino acid substitutions (Fig. 5B). Separating the ArMV isolates
into two groups based on the nature of the X2–NTB cleavage site
reveals 12 changes that are present in all representative members
of the two groups (shown by the yellow box for the Lv and barley
isolates and by the blue box for the NW and Du13 grapevine
isolates, Fig. 5B). Although many changes are conserved, a few
changes are non-conserved or semi-conserved (Gln6 to Lys, Val152
to Lys, His167 to Tyr and Ser/Thr201 to Ile). Further studies will be
necessary to determine whether these or other amino acid
changes are responsible for the increased activity of the ArMV-
Lv protease on selected cleavage sites within the RNA1-encoded
polyprotein.Materials and methods
Virus isolates
ArMV-NW (Wetzel et al., 2004, 2001) originated from infected
“Pinot gris” grapevines in Hambach (near Neustadt an der Wein-
strasse). ArMV-Lv (Dupuis et al., 2008) was obtained from the
Deutsche Sammlung Mikroorganismen und Zellkulturen GmbH,
Messerweg 11/12, 38104 Braunschweig, Germany (DSMZ, ArMV
isolate PV046). The two isolates were propagated on C. quinoa.
Virus puriﬁcation and extraction of the viral genomic RNAs were
done as previously described (Pinck et al., 1988).
cDNA synthesis, cloning and sequencing
Puriﬁed viral RNA or total RNA extracted from infected C.
quinoa leaves using the Omniprep RNA extraction kit (Ivagen,
France) or the TRIreagent (Sigma) was used as a template for one-
tube RT/PCR ampliﬁcation reactions (One Step RT-PCR system,
Invitrogen). The resulting ampliﬁed products were cloned into the
vector pT-PCR (Wassenegger et al., 1994) and sequenced, or
sequenced directly. Sequences were compiled and analyzed using
the DNASIS program package (Hitachi).
Construction of the full-length ArMV-NW cDNA clones
To assemble full-length clones of ArMV-NW, cDNA fragments
from existing clones for both RNA1 and RNA2 (Wetzel et al., 2004,
2001) were used whenever possible based on the presence of unique
restriction sites in the RNA1 or RNA2 sequences. The fragments were
assembled step by step in the plasmid pCassII (Shi et al., 1997), which
contains a double 35S promoter and a 35S terminator. One-step
overlap extension PCR (Urban et al., 1997) was used to fuse the
sequences corresponding to the 50 ends of the viral RNAs to the 35S
promoter transcription start of the plasmid pCassII. For the 30 ends,
clones containing a poly(A) with 30 adenine residues were selected
for the assembly of both RNA1 and RNA2. For areas of the viral
genome in which no clones with appropriate restriction sites were
available, unique restriction sites were introduced in the ArMV-NW
sequence by one-step overlap extension RT-PCR from puriﬁed viral
RNA using primers containing sequences corresponding to unique
Fig. 5. Comparison of the amino acid sequence of the X2–NTB cleavage site and of
the protease from ArMV isolates. Sequences were aligned with the ClustalW
program using the following Genbank accession numbers EU617326 (ArMV-Lv),
AY303786 (ArMV-NW), GQ369526-8 (ArMV-Ba1–3) and JQ975057 (ArMV-DU13)
(Dupuis et al., 2008; Lopez-Fabuel et al., 2013; Wetzel et al., 2004). The symbols
below the alignment represent positions of amino acid identity (n) or positions
with conserved (:) or semi-conserved (.) substitutions (see http://www.ebi.ac.uk/
Tools/clustalw2/help.html#alignment for further details). The (+) symbols above
the sequence show amino acids that differ between ArMV-NW and ArMV-Lv.
(A) Alignment of the amino acid sequence surrounding the X2–NTB cleavage site.
The scissile bond is shown by the forward slash. (B) Alignment of the protease
amino acid sequence. Gray and pink boxes indicate amino acids of the catalytic
triad (His43, Glu87, Cys179) and substrate-binding pocket (Leu197), respectively. Blue
and yellow boxes indicate amino acid substitutions that were conserved only in the
NW and Du13 isolates, or only in the Lv and Ba1–3 isolates, respectively.
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coding sequence. All the cloning and sub-cloning experiments were
done according to standard procedures (Sambrook and Russel, 2001).
The sequences of the primers used for the construction of the clones
can be obtained upon request.
Construction of the ArMV RNA1 chimeric clones
For the construction of the ArMV RNA1 full-length chimeric
clones between ArMV-NW and -Lv, cDNA fragments of ArMV-Lv
were ampliﬁed by PCR from ArMV-Lv clones using speciﬁc primers
containing the sequences of restriction sites to be used for the
cloning procedure. The resulting RT/PCR products were digested
with the corresponding restriction enzymes and ligated into the
ArMV-NW RNA1 clone similarly digested. Additional unique
restriction sites were introduced whenever needed by one-stepoverlap extension PCR using silent mutations in the primer
sequences. Punctual amino acid changes in the coding sequence
were obtained by one-step overlap extension PCR, with the
corresponding mutations introduced in the primer sequences.
All the clones were veriﬁed by restriction enzyme digestion and
complete sequencing of the inserted fragment.
Construction of the chimeric clones for in vitro transcription and
translation
The ArMV-NW, or chimeric ArMV-NW/Lv RNA1 full-length
clones were used as templates for ampliﬁcation by PCR using
Phusion High Fidelity DNA Polymerase (New Englands Biolabs)
and primers containing unique restriction sites also present in the
multiple cloning site of the pCITE 4A plasmid (Novagen). The
resulting PCR products containing the coding regions for the X1,
X2, NTB, VPg and Pro domains (X1–Pro polyprotein) were digested
with the corresponding restriction enzymes and ligated into the
multiple cloning site of the pCITE 4A plasmid similarly digested.
The same strategy was used to clone the coding region for the 2A,
MP and CP domains from ArMV-NW RNA2 full-length cDNA clones
into the pCITE 4A plasmid. All the clones were veriﬁed by
restriction enzyme digestion and complete sequencing of the
inserted fragment.
In vitro transcription and translation experiments
Coupled in vitro transcription and translation reactions and
in vitro processing assays were conducted as described previously
(Wetzel et al., 2008). The TNT coupled rabbit reticulocyte system
(Promega) and [35S]-methionine were used to produce labeled
translation products (incubation at 30 1C for 90 min). After addi-
tion of RNase A and cold methionine to terminate translation of
labeled products, the reaction was diluted in processing buffer
(Wetzel et al., 2008) and incubated at 16 1C to allow for proteolytic
processing. Each experiment was conducted at least three times
and a representative gel is shown. In the case of trans-processing
assays, translation products from the various X1–Pro chimeric
constructs were used as a source of protease. Processing products
were synthesized as above but in the presence of cold methionine.
The cold X1–Pro products were then added to the radiolabeled P2
polyprotein produced by in vitro translation in the presence of
[35S]-methionine. Proteolytic processing was allowed to occur by
incubation of the mixture at 21 1C and samples were removed at
regular time intervals. To normalize the concentration of X1–Pro
translation products added to the reaction, [35S]-methionine
was added to a portion of the cold X1–Pro translation reaction.
Translation products were separated by denaturing polyacryla-
mide gel electrophoresis (SDS–PAGE). Gels were exposed to ﬁlms
or to a phosphorimager (Cyclone Plus, Perkin Elmer). The radio-
activity present in each band was estimated using the OptiQuant
program.
Mechanical inoculations onto C. quinoa
Five micrograms (mg) of plasmids corresponding to ArMV-NW
RNA1 (or one of the chimeric constructs) and ArMV-NW RNA2
were mixed with inoculation buffer (0.03 M K2HPO4 pH 9.2,
0.05 M glycine, 1% bentonite, 1% celite) and rub-inoculated on C.
quinoa at the 6–8 leaf stage. Plants were monitored for symptom
development, and ELISA tests were performed at 14 dpi using
ArMV antisera from Bioreba (Switzerland). Total RNA was
extracted from systemic leaves of infected plants at 12 dpi. In
each case, RT/PCR was performed to amplify the regions of the
genomic viral RNA corresponding to the inserted chimeric frag-
ments and the resulting RT/PCR products were sequenced directly.
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Northern blots
For the detection of viral genomic RNA, 1 mg of total RNA
isolated from infected C. quinoa was separated on a 1% agarose–
formaldehyde gel, blotted by capillarity on a nylon membrane
(Hybond N+, Amersham) in 20 SSC buffer (1.5 M NaCl, 0.15 M
trisodium citrate, pH 7.0), and cross-linked under UV light
(310 nm). For the preparation of the probe, 25 ng of a puriﬁed
PCR-ampliﬁed fragment (either a 300 bp fragment from the
polymerase coding region of ArMV-NW RNA1 or a 400 bp frag-
ment from the MP–CP coding region of ArMV-NW RNA2), was
labeled with [α-32P]dCTP (3000 Ci/mmol, Perkin-Elmer) using the
Decalabel DNA labeling kit (Fermentas) following the recommen-
dations of the manufacturer. The membranes were hybridized at
65 1C for 16 h in PerfectHyb Plus buffer (Sigma). Post-hybridization
washings were performed at 65 1C in 2% SDS, 2 SSC (20 min)
and 1% SDS, 1 SSC (20 min), and 0.1% SDS, 0.5 SSC (10 min).
Stripping of the membranes (for hybridization with another probe)
was performed at 85 1C in 0.1% SDS, 0.1 SSC (230 min), and
1 min in 2 SSC at room temperature. Fuji screens and a scan
phosphoimager Pharaos FxPlus molecular imager (Biorad) were
used to visualize and quantify the hybridization signals. The
quantiﬁed hybridization signals were normalized using the load-
ing controls for each sample. Loading controls (ethidium bromide
stain of a ribosomal RNA band) were quantiﬁed by densitometry
analysis of the scanned gels. Average and standard deviation of the
normalized quantiﬁcations were calculated using values derived
from three independent experiments.
Sequence alignments
Multiple amino acid sequences were aligned using the ClustalW
program (Chenna et al., 2003).
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